Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lymphoma, B-Cell × Nivolumab × Clear all

Phase

Status

Unknown 2 Recruiting 2 Active not recruiting 2 Withdrawn 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 15 Carcinoma, Non-Small-Cell Lung 13 Squamous Cell Carcinoma of Head and Neck 6 Colorectal Neoplasms 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Myelodysplastic Syndromes 2 Hematologic Neoplasms 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Hepatocellular 2 Adenocarcinoma 2 Xeroderma Pigmentosum 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Resectable Non-Small Cell Lung Cancer 1 Resectable Hepatocellular Carcinoma 1

Interventions

Rituximab 3 ibrutinib 2 fludarabine phosphate 2 fludarabine 2 blinatumomab 2 Vorinostat 2 Radiation 2 Lenalidomide 2 Gemcitabine 2 Cyclophosphamide 2 umbralisib 1 ublituximab 1 tafasitamab 1 polatuzumab vedotin 1 pembrolizumab 1 ofatumumab 1 molibresib 1 magrolimab 1 iberdomide 1 entinostat 1 cirmtuzumab 1 asparaginase erwinia chrysanthemi recombinant 1 X-Rays 1 Tacrolimus 1 Stem Cell Transplantation 1 Spinal Puncture 1 Roflumilast 1 Radiotherapy 1 Phantoms, Imaging 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03920631 2021-03-23

MicroBLITZ

Duke University

Phase 1 Withdrawn

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡